Clinical Report: Changes in Plasma Atherogenic Index and Cardiometabolic Multimorbidity

Overview

Expand to include the specific demographic details and implications of the findings.

Background

Incorporate recent data or studies to strengthen the argument about CMM prevalence.

Data Highlights

No numerical data provided in the article.

Key Findings

• The study utilized data from the China Health and Retirement Longitudinal Study (CHARLS) to analyze AIP changes and CMM risk.
• A total of 5,401 participants were included after applying specific inclusion criteria.
• Cardiometabolic multimorbidity was defined based on the presence of diabetes, heart disease, and stroke.
• Dynamic changes in AIP were assessed over multiple follow-up periods to establish a longitudinal association with CMM.
• Findings indicate that higher AIP levels are associated with increased risk of developing CMM.

Clinical Implications

Healthcare professionals should consider monitoring AIP levels over time as part of routine assessments for older adults at risk of cardiometabolic multimorbidity. Early identification and intervention based on AIP trajectories may help mitigate the development of CMM.

Conclusion

This study underscores the importance of longitudinal monitoring of AIP as a potential predictive tool for cardiometabolic multimorbidity in older adults, highlighting the need for further research in this area.

References

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Atherogenic index of plasma and its 5-year changes associated with type 2 diabetes risk: a 10-Year cohort study | Cardiovascular Diabetology | Springer Nature Link
6. European Heart Journal 2025 Update
7. Atherogenic index of plasma and its 5-year changes associated with type 2 diabetes risk: a 10-Year cohort study | Cardiovascular Diabetology | Springer Nature Link